Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

November 21, 2023 | John Murphy | Leave a Comment

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

Hironori Tsuchiya, Christos Rahiotis, Academic Editor and Nikolaos Gkantidis, Academic EditorDent J (Basel). 2023 Jun; 11(6): 140. Published online 2023 May 25. doi: 10.3390/dj11060140, PMCID: PMC10297082 PMID: 37366663 Abstract Since the worldwide spread of severe acute respiratory syndrome…[...]

November 19, 2023 | John Murphy | Leave a Comment

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

Theo Sanderson, Ryan Hisner, I’ah Donovan-Banfield, Hassan Hartman, Alessandra Løchen, Thomas P. Peacock & Christopher Ruis Nature (2023) Cite this article Abstract Molnupiravir, an antiviral medication widely used against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), acts by inducing…[...]

November 19, 2023 | John Murphy | Leave a Comment

Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19A Randomized Clinical Trial

Susanna Naggie, MD, MHS1,2; David R. Boulware, MD, MPH3; Christopher J. Lindsell, PhD4; et alThomas G. Stewart, PhD5; Alex J. Slandzicki, MD6; Stephen, C. Lim, MD Jonathan Cohen, MD8; David Kavtaradze, MD9, Arch Amon, MD10, et. al for the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. JAMA. 2023;329(11):888-897. doi:10.1001/jama.2023.1650 Question Does ivermectin,…[...]

November 18, 2023 | John Murphy | Leave a Comment

Simvastatin in Critically Ill Patients with Covid-19

November 2, 2023, NEJM Abstract BACKGROUND The efficacy of simvastatin in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. METHODS In an ongoing international, multifactorial, adaptive platform, randomized,…[...]

November 14, 2023 | John Murphy | Leave a Comment

COVID-19 Therapeutics for Nonhospitalized Patients

Rajesh T. Gandhi, MD1; Preeti N. Malani, MD, MSJ2,3; Carlos del Rio, MD4, JAMA. 2022;327(7):617-618. doi:10.1001/jama.2022.0335 Substantial progress has been made in therapeutics for nonhospitalized patients with COVID-19, but supply of and access to treatment remain limited. This Viewpoint…[...]

November 14, 2023 | John Murphy | Leave a Comment

Hydroxychloroquine Associated With Lower COVID-19 Mortality: French Study

NOV 03, 2023 - Authored by Zachary Stieber The Epoch Times People who received hydroxychloroquine were less likely to die than those who did not, according to a new study.…[...]

November 12, 2023 | John Murphy | Leave a Comment

European Regulator Confirms Pfizer Did Not Highlight DNA Sequence In COVID-19 Vaccine

NOV 03, 2023 - Authored by Zachary Stieber The Epoch Times Pfizer did not highlight a DNA sequence in its COVID-19 vaccine, a European regulator has confirmed. "While the full DNA…[...]

November 12, 2023 | John Murphy | Leave a Comment

Narcolepsy following COVID‐19: A case report and review of potential mechanisms

Yazdani Roya, 1 Barzkar Farzaneh, 2 Almasi‐Dooghaee Mostafa, 1 Shojaie Mahsa, 1 and Zamani Babak 1 Clin Case Rep. 2023 Jun; 11(6): e7370. Published online 2023 May 25.https://doi.org/10.1002/ccr3.7370, PMCID: PMC10213711, PMID: 37251741 Abstract Key Clinical Message The immune activation in COVID‐19 may…[...]

November 9, 2023 | John Murphy | Leave a Comment

FDA, CDC Hid Data On Spike In COVID Cases Among The Vaccinated: Documents

SEP 2023 - Authored by Zachary Stieber The Epoch Times COVID-19 cases among vaccinated seniors soared in 2021, according to newly disclosed data that was acquired by U.S. health agencies…[...]

November 7, 2023 | John Murphy | Leave a Comment

COVID-19 Long-haul Fatigue Might be Similar to Chronic Fatigue Syndrome and Treated in a Similar Manner

There is no cure or approved treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, some symptoms can be treated or managed. Treating these symptoms might provide relief for some patients…[...]